- Report
- October 2024
- 185 Pages
Global
From €3389EUR$3,545USD£2,837GBP
€3766EUR$3,939USD£3,152GBP
- Report
- September 2024
- 120 Pages
Global
From €5689EUR$5,950USD£4,762GBP
- Report
- April 2025
- 246 Pages
Global
From €5211EUR$5,450USD£4,362GBP
- Report
- March 2025
- 200 Pages
Global
From €4293EUR$4,490USD£3,593GBP
- Report
- January 2025
- 180 Pages
Global
From €4302EUR$4,500USD£3,601GBP
- Report
- July 2024
- 150 Pages
Global
From €3585EUR$3,750USD£3,001GBP
- Report
- December 2024
- 150 Pages
Global
From €4637EUR$4,850USD£3,882GBP
- Report
- August 2024
- 200 Pages
Global
From €4732EUR$4,949USD£3,961GBP
- Report
- February 2025
- 200 Pages
Global
From €4293EUR$4,490USD£3,593GBP
- Report
- July 2024
- 150 Pages
Global
From €3585EUR$3,750USD£3,001GBP
- Report
- March 2022
- 273 Pages
Global
From €3585EUR$3,750USD£3,001GBP
- Report
- February 2024
- 111 Pages
Global
From €4541EUR$4,750USD£3,802GBP
- Report
- December 2023
- 201 Pages
Global
€4776EUR$4,995USD£3,998GBP
- Report
- October 2024
- 70 Pages
Global
From €908EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
North America
From €908EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
Asia Pacific
From €908EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
Latin America
From €908EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
Europe
From €908EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
China
From €908EUR$950USD£760GBP
- Report
- October 2024
- 70 Pages
France
From €908EUR$950USD£760GBP

The Hospital Acquired Infection Control market is a subset of the Infectious Diseases Drugs market, focusing on the prevention and treatment of infections acquired in a hospital setting. This includes a range of drugs, such as antibiotics, antivirals, antifungals, and antiparasitics, as well as other treatments such as vaccines and immunoglobulins. The market is driven by the need to reduce the risk of infection in hospitals, as well as the increasing prevalence of antibiotic-resistant bacteria.
The market is highly competitive, with a range of large and small companies offering products and services. Major players include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Johnson & Johnson. Other companies in the market include AstraZeneca, Novartis, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more